Clinical Trials List
Protocol Number22489
2023-11-15 - 2023-11-28
Phase III
Terminated1
ICD-10I48.0
Paroxysmal atrial fibrillation
ICD-10I48.2
Chronic atrial fibrillation
ICD-10I48.91
Unspecified atrial fibrillation
ICD-9427.31
Atrial fibrillation
-
Trial Applicant
BAYER TAIWAN COMPANY LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 李慶威 無
- 黃少嵩 無
- 蔡依霖 無
- 吳承學 無
- 張俊欽 無
- 廖若男 無
- Hao-min Cheng 無
- Shih-Hsien Sung 無
- 郭泠 無
- Tze-Fan Chao 無
- Tse-Min Lu 無
- Wen-Chung Yu 無
- Yao-Ping Lin 無
- 黃偉銘 無
- 蔡明村 無
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
100 participants
-
Global
2272 participants
